Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-010651
Filing Date
2013-08-13
Accepted
2013-08-13 16:50:25
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insy20130630_10q.htm 10-Q 1033949
2 EXHIBIT 31.1 ex31-1.htm EX-31 15283
3 EXHIBIT 31.2 ex31-2.htm EX-31 15130
4 EXHIBIT 32.1 ex32-1.htm EX-32 7323
5 EXHIBIT 32.2 ex32-2.htm EX-32 6790
  Complete submission text file 0001437749-13-010651.txt   6138123

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS insy-20130630.xml EX-101.INS 635485
7 EXHIBIT 101.SCH insy-20130630.xsd EX-101.SCH 33579
8 EXHIBIT 101.CAL insy-20130630_cal.xml EX-101.CAL 25789
9 EXHIBIT 101.DEF insy-20130630_def.xml EX-101.DEF 155443
10 EXHIBIT 101.LAB insy-20130630_lab.xml EX-101.LAB 262898
11 EXHIBIT 101.PRE insy-20130630_pre.xml EX-101.PRE 162603
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 131033650
SIC: 2834 Pharmaceutical Preparations